BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18774542)

  • 1. Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy.
    Mikolajewska P; Juzeniene A; Moan J
    Transl Res; 2008 Sep; 152(3):128-33. PubMed ID: 18774542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
    van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
    Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
    van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
    Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
    Schary N; Novak B; Kämper L; Yousf A; Lübbert H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
    Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
    Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
    Novak B; Heesen L; Schary N; Lübbert H
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
    Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
    Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
    Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin.
    Pudroma X; Moan J; Ma LW; Iani V; Juzeniene A
    Exp Dermatol; 2009 Nov; 18(11):985-7. PubMed ID: 19469901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
    Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
    Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
    Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
    J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.
    Anand S; Honari G; Hasan T; Elson P; Maytin EV
    Clin Cancer Res; 2009 May; 15(10):3333-43. PubMed ID: 19447864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
    van der Veen N; de Bruijn HS; Berg RJ; Star WM
    Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.
    León D; Buchegger K; Silva R; Riquelme I; Viscarra T; Mora-Lagos B; Zanella L; Schafer F; Kurachi C; Roa JC; Ili C; Brebi P
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
    Juzeniene A; Iani V; Moan J
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K; Brooke RC; Farrar W; Rhodes LE
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
    Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
    J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.